PRO-DEX, INC. Income Tax (Expense) Benefit, Continuing Operations, Government Grants
PRO-DEX, INC. (PDEX) reported Income Tax (Expense) Benefit, Continuing Operations, Government Grants of $54.00 thousand for the 6-month period ending 2017-12-31, per its 10-Q filed 2018-02-08.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefitContinuingOperationsGovernmentGrants · last filed 2018-02-08
- 2017-12-31: Income Tax (Expense) Benefit, Continuing Operations, Government Grants 6 month $54.00K.
| Period end | Income Tax (Expense) Benefit, Continuing Operations, Government Grants 6 month |
|---|---|
| 2017-12-31 | $54.00K 10-Q · filed 2018-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |